4626 - 4650 of 7877 Results
Title
Year
- Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease2020RESTRICTEDTitle: Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s DiseaseJournal Name: MoleculesPublisher: MDPI AGVol: 25Issue #: 3Start Page: 453End Page: 453Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules25030453Best OA location URL: https://www.mdpi.com/1420-3049/25/3/453/pdf?version=1580039503Citation Count: 47
- Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson’s disease2020RESTRICTEDTitle: Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson’s diseaseJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 103Issue #:Start Page: 101807End Page: 101807Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.artmed.2020.101807Citation Count: 24
- Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease2020OPENTitle: Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 3Start Page: 960End Page: 975Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaa020Best OA location URL: https://doi.org/10.1093/brain/awaa020Citation Count: 64
- Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score2020OPENTitle: Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk ScoreJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 774End Page: 780Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27974Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975556Citation Count: 61
-
OPENTitle: Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tauJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 3Start Page: 932End Page: 943Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa021Best OA location URL: https://academic.oup.com/brain/article-pdf/143/3/932/32963580/awaa021.pdfCitation Count: 54
- White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study2020RESTRICTEDTitle: White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 100Issue #:Start Page: 109871End Page: 109871Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2020.109871Citation Count: 27
-
OPENTitle: Clinical and Neuropathological Features Associated With Loss of RAB39BJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 687End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27951Best OA location URL: http://minerva-access.unimelb.edu.au/bitstreams/117ab965-44a2-574b-b21a-b15eccdf37c9/downloadCitation Count: 16
- EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease2020OPENTitle: EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 2Start Page: 543End Page: 558Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191841Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191841?id=journal-of-parkinsons-disease%2Fjpd191841Citation Count: 23
-
RESTRICTEDTitle: Gait characterization for patients with orthostatic tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 71Issue #:Start Page: 23End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.007Citation Count: 7
- mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s disease2020OPENTitle: mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s diseaseJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-019-0214-xBest OA location URL: https://www.nature.com/articles/s41746-019-0214-x.pdfCitation Count: 94
-
OPENTitle: Network Analysis for Complex Neurodegenerative DiseasesJournal Name: Current Genetic Medicine ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 17End Page: 25Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40142-020-00181-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40142-020-00181-z.pdfCitation Count: 16
- Utilization Behavior Associated with Communicating Hydrocephalus with Resolution Post–Ventriculoperitoneal Shunting2020OPENTitle: Utilization Behavior Associated with Communicating Hydrocephalus with Resolution Post–Ventriculoperitoneal ShuntingJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 338End Page: 339Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12898Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12898Citation Count: 0
-
OPENTitle: Falls Risk in Relation to Activity Exposure in High-Risk Older AdultsJournal Name: The Journals of Gerontology: Series APublisher: Oxford University Press (OUP)Vol: 75Issue #: 6Start Page: 1198End Page: 1205Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/gerona/glaa007Best OA location URL: https://academic.oup.com/biomedgerontology/article-pdf/75/6/1198/33283332/glaa007.pdfCitation Count: 54
-
OPENTitle: Comparison of an Online-Only Parkinson’s Disease Research Cohort to Cohorts Assessed In PersonJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 2Start Page: 677End Page: 691Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191808Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191808?id=journal-of-parkinsons-disease%2Fjpd191808Citation Count: 23
- Tactile and proprioceptive dysfunction differentiates cervical dystonia with and without tremor2020RESTRICTEDTitle: Tactile and proprioceptive dysfunction differentiates cervical dystonia with and without tremorJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008916Citation Count: 27
-
RESTRICTEDTitle: A pooled meta-analysis of GPi and STN deep brain stimulation outcomes for cervical dystoniaJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 5Start Page: 1278End Page: 1290Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-09703-9Citation Count: 28
- The highly selective mGlu2 receptor positive allosteric modulator LY‐487,379 alleviates l‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's disease2020RESTRICTEDTitle: The highly selective mGlu2 receptor positive allosteric modulator LY‐487,379 alleviates l‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 51Issue #: 12Start Page: 2412End Page: 2422Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14679Citation Count: 15
-
RESTRICTEDTitle: CLU rs11136000 Promotes Early Cognitive Decline in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 3Start Page: 508End Page: 513Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27949Citation Count: 15
- Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside‐Containing Nanoliposomes2020OPENTitle: Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside‐Containing NanoliposomesJournal Name: Journal of the American Heart AssociationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1161/jaha.119.014810Best OA location URL: https://doi.org/10.1161/jaha.119.014810Citation Count: 20
-
OPENTitle: Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in AdultsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 4Start Page: 461End Page: 461Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamaneurol.2019.4565Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2758316/jamaneurology_isaacson_2020_oi_190108.pdfCitation Count: 53
- A simple, versatile and robust centrifugation‐based filtration protocol for the isolation and quantification of α‐synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α‐synuclein research2020OPENTitle: A simple, versatile and robust centrifugation‐based filtration protocol for the isolation and quantification of α‐synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α‐synuclein researchJournal Name: Journal of NeurochemistryPublisher: WileyVol: 153Issue #: 1Start Page: 103End Page: 119Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/jnc.14955Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14955Citation Count: 50
-
OPENTitle: Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case reportJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 71Issue #:Start Page: 36End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.013Best OA location URL: https://europepmc.org/articles/pmc7085430?pdf=renderCitation Count: 11
-
RESTRICTEDTitle: Linear Ubiquitin Chains: Cellular Functions and Strategies for Detection and QuantificationJournal Name: Frontiers in ChemistryPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fchem.2019.00915Best OA location URL: https://www.frontiersin.org/articles/10.3389/fchem.2019.00915/pdfCitation Count: 71
- Utilization Patterns of Amantadine in Parkinson’s Disease Patients Enrolled in the French COPARK Study2020RESTRICTEDTitle: Utilization Patterns of Amantadine in Parkinson’s Disease Patients Enrolled in the French COPARK StudyJournal Name: Drugs & AgingPublisher: Springer Science and Business Media LLCVol: 37Issue #: 3Start Page: 215End Page: 223Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40266-019-00740-2Citation Count: 12
- Striatum Shape Hypertrophy in Early Stage Parkinson’s Disease With Excessive Daytime Sleepiness2020OPENTitle: Striatum Shape Hypertrophy in Early Stage Parkinson’s Disease With Excessive Daytime SleepinessJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2019.01353Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2019.01353/pdfCitation Count: 12